Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James H Pickar

Showing results (11-20 of 65) with videos related to

Pageof 7
Sort By:
Maturitas|December 4, 2014
Selective estrogen receptor modulators (SERMs): a review of clinical dataSebastian Mirkin, James H Pickar
International Journal of Women'S Health|August 23, 2013
Management of osteoporosis and menopausal symptoms: focus on bazedoxifene/conjugated estrogen combinationSebastian Mirkin, James H Pickar
Menopause (New York, N.Y.)|September 30, 2015
Update on medical and regulatory issues pertaining to compounded and FDA-approved drugs, including hormone therapyJoAnn V Pinkerton, James H Pickar
Current Opinion in Pharmacology|December 4, 2003
Estrogens in postmenopausal women: recent insightsGinger D Constantine, James H Pickar
Post Reproductive Health|August 21, 2015
Selective estrogen receptor modulators and the combination therapy conjugated estrogens/bazedoxifene: A review of effects on the breastJames H Pickar, Barry S Komm
Climacteric : the Journal of the International Menopause Society|January 18, 2021
Managing the menopause: the question of evidenceJames H Pickar, Rodney J Baber
Menopause (New York, N.Y.)|March 14, 2018
Tissue selective estrogen complex (TSEC): a reviewJames H Pickar, Matthieu Boucher, Diana Morgenstern
Women'S Health (London, England)|March 8, 2014
Conjugated estrogen/bazedoxifene tablets for the treatment of moderate-to-severe vasomotor symptoms associated with menopauseSebastian Mirkin, Barry Komm, James H Pickar
Maturitas|June 29, 2010
SERMs: progress and future perspectivesJames H Pickar, Tanya MacNeil, Kathleen Ohleth
Expert Opinion on Drug Safety|August 8, 2013
Conjugated estrogens for the treatment of menopausal symptoms: a review of safety dataSebastian Mirkin, Barry S Komm, James H Pickar
Pageof 7

Showing results (11-20 of 65) with videos related to

Sort By:
Pageof 7
Maturitas|December 4, 2014
Selective estrogen receptor modulators (SERMs): a review of clinical dataSebastian Mirkin, James H Pickar
International Journal of Women'S Health|August 23, 2013
Management of osteoporosis and menopausal symptoms: focus on bazedoxifene/conjugated estrogen combinationSebastian Mirkin, James H Pickar
Menopause (New York, N.Y.)|September 30, 2015
Update on medical and regulatory issues pertaining to compounded and FDA-approved drugs, including hormone therapyJoAnn V Pinkerton, James H Pickar
Current Opinion in Pharmacology|December 4, 2003
Estrogens in postmenopausal women: recent insightsGinger D Constantine, James H Pickar
Post Reproductive Health|August 21, 2015
Selective estrogen receptor modulators and the combination therapy conjugated estrogens/bazedoxifene: A review of effects on the breastJames H Pickar, Barry S Komm
Climacteric : the Journal of the International Menopause Society|January 18, 2021
Managing the menopause: the question of evidenceJames H Pickar, Rodney J Baber
Menopause (New York, N.Y.)|March 14, 2018
Tissue selective estrogen complex (TSEC): a reviewJames H Pickar, Matthieu Boucher, Diana Morgenstern
Women'S Health (London, England)|March 8, 2014
Conjugated estrogen/bazedoxifene tablets for the treatment of moderate-to-severe vasomotor symptoms associated with menopauseSebastian Mirkin, Barry Komm, James H Pickar
Maturitas|June 29, 2010
SERMs: progress and future perspectivesJames H Pickar, Tanya MacNeil, Kathleen Ohleth
Expert Opinion on Drug Safety|August 8, 2013
Conjugated estrogens for the treatment of menopausal symptoms: a review of safety dataSebastian Mirkin, Barry S Komm, James H Pickar
Pageof 7